CEO Interview
Bioprinted Mini-Heart Addresses a $5B+ Market Opportunity
Company Overview
BIOLIFE4D Corp. is a pioneering, development stage biotech company that plans to leverage current advances in life sciences and cardiac tissue engineering to build human hearts first for cardiotoxicity testing and then potentially for suitable implantation.
We plan to strategically position ourselves at the center of an unprecedented convergence of regenerative medicine, stem cell biology, additive manufacturing (3D printing), and computing technology – all having reached a level of maturity where we believe that commercially viable bioprinting solutions can be created through optimization, not invention. With BIOLIFE4D, a patient-specific, fully functioning heart may be created through 3D bioprinting using the patient’s own cells, potentially eliminating the challenges of organ rejection and long donor waiting lists that plague existing organ transplant methods.
BIOLIFE4D is committed to perfecting the technology to make viable organ repair and replacement an accessible and affordable reality.
Contact Information:
RedChip.com | 1-800-REDCHIP (733-2447)
Disclosure
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
The information contained herein is not intended to be used as the basis for investment decisions and should not be construed as advice intended to meet the particular investment needs of any investor. The information contained herein is not a representation or warranty and is not an offer or solicitation of an offer to buy or sell any security. To the fullest extent of the law, RedChip Companies, Inc., our specialists, advisors, and partners will not be liable to any person or entity for the quality, accuracy, completeness, reliability or timeliness of the information provided, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information provided to any person or entity (including but not limited to lost profits, loss of opportunities, trading losses and damages that may result from any inaccuracy or incompleteness of this information).
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov.
BIOLIFE4D is a client of RedChip Companies, Inc. BIOLIFE4D agreed to pay RedChip Companies, Inc., a $7,500 monthly cash fee pre-IPO, $12,500 post-IPO, and 6,000 shares of common stock, beginning in April 2022, for 6 months of RedChip investor awareness services.
Additional risks discussed in the Risk Factors section of our Prospectus filed with the Securities and Exchange Commission (the “SEC”) on June 17, 2022 as such risk factors may be updated from time to time in our periodic filings with the SEC, all of which are accessible on the SEC’s website at http://www.sec.gov. We operate in a rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Given these uncertainties, you should not place undue reliance on forward-looking statements contained herein. You should read this presentation and the documents we have filed with the SEC with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Intellectual Property Disclosure This presentation contains references to our trademarks and to trademarks belonging to other entities. Solely for convenience, trademarks and trade names herein, including logos, artwork, and other visual displays, appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend the use or display of other companies’ trade names or trademarks to imply a relationship with or endorsement from us.
Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. RedChip investor awareness services include the preparation of a research profile(s), multimedia marketing, and other awareness services.
For a list of references, please visit this site
Privacy Policy
Website Powered By
© 2024 Redchip Companies, Inc.